Forte Biosciences, Inc. Announces Second Quarter 2020 Results and Provides General Business Update News General Forte Biosciences, Inc. Announces Second Quarter 2020 Results and Provides General Business Update Krystal K. Lindahl August 11, 2020 TORRANCE, Calif.–(BUSINESS WIRE)–Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the second quarter... Read More Read more about Forte Biosciences, Inc. Announces Second Quarter 2020 Results and Provides General Business Update
